Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Karonitsch

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Arthritis Research & Therapy|March 14, 2016
Nicotinic acetylcholine receptors modulate osteoclastogenesisPeter Mandl, Silvia Hayer, Thomas Karonitsch, et al.
Arthritis and Rheumatism|July 30, 2010
CCL17/thymus and activation-related chemokine in Churg-Strauss syndromeTomáš Dallos, Gisela Ruiz Heiland, Johanna Strehl, et al.
BMJ Open|September 23, 2025
Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort studyElisabeth Simader, Felix Kartnig, Selma Tobudic, et al.
Annals of the Rheumatic Diseases|March 19, 2022
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort studyPeter Mandl, Selma Tobudic, Helmut Haslacher, et al.
Rheumatology (Oxford, England)|December 12, 2017
Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytesThomas Karonitsch, Denise Beckmann, Karolina Dalwigk, et al.
Rheumatology (Oxford, England)|May 28, 2025
Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational studyKastriot Kastrati, Thomas Karonitsch, Hanien Rajab, et al.
Experimental & Molecular Medicine|July 10, 2019
IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes : JAKinibs suppress the interferon response in RA-FLSsMichael Bonelli, Karolina Dalwigk, Alexander Platzer, et al.
The American Journal of Medicine|July 9, 2010
Hereditary hemochromatosis as a risk factor for joint replacement surgeryEnijad Sahinbegovic, Tomás Dallos, Elmar Aigner, et al.
Arthritis and Rheumatism|August 20, 2010
Musculoskeletal disease burden of hereditary hemochromatosisEnijad Sahinbegovic, Tomáš Dallos, Elmar Aigner, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|May 1, 2009
Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cellsThomas Karonitsch, Eva Feierl, Carl Walter Steiner, et al.
Arthritis Research & Therapy|March 14, 2016
Nicotinic acetylcholine receptors modulate osteoclastogenesisPeter Mandl, Silvia Hayer, Thomas Karonitsch, et al.
Arthritis and Rheumatism|July 30, 2010
CCL17/thymus and activation-related chemokine in Churg-Strauss syndromeTomáš Dallos, Gisela Ruiz Heiland, Johanna Strehl, et al.
BMJ Open|September 23, 2025
Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort studyElisabeth Simader, Felix Kartnig, Selma Tobudic, et al.
Annals of the Rheumatic Diseases|March 19, 2022
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort studyPeter Mandl, Selma Tobudic, Helmut Haslacher, et al.
Rheumatology (Oxford, England)|December 12, 2017
Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytesThomas Karonitsch, Denise Beckmann, Karolina Dalwigk, et al.
Rheumatology (Oxford, England)|May 28, 2025
Immunoadsorption as a novel therapy for refractory idiopathic inflammatory myopathies: a retrospective observational studyKastriot Kastrati, Thomas Karonitsch, Hanien Rajab, et al.
Experimental & Molecular Medicine|July 10, 2019
IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes : JAKinibs suppress the interferon response in RA-FLSsMichael Bonelli, Karolina Dalwigk, Alexander Platzer, et al.
The American Journal of Medicine|July 9, 2010
Hereditary hemochromatosis as a risk factor for joint replacement surgeryEnijad Sahinbegovic, Tomás Dallos, Elmar Aigner, et al.
Arthritis and Rheumatism|August 20, 2010
Musculoskeletal disease burden of hereditary hemochromatosisEnijad Sahinbegovic, Tomáš Dallos, Elmar Aigner, et al.
Pageof 4